Lupin Q2 Preview Strong Profit Growth of 42% YoY Driven by Robust India and US Sales
Lupin Limited, one of the largest Indian pharmaceuticals, will declare its financial results for the second quarter of fiscal year 2024-25 (Q2FY25) on Thursday, November 7. Evaluators foretasted an excellent…